November put buying suggests further drop.The November 15th $8 put options onTeva Pharmaceutical (TEVA) saw over 17,000 contracts trade against a prior open interest of 243, indicating a 70-fold surge in volume on the trade. With shares of Teva around $7, the $8 puts are already $1 in-the-money and should move penny-for-penny with any further drop in shares. At a cost of $1.44, the option also has about a penny a day in time premium attached to it. Shares of Teva have slid by 68 percent in the past year, and the company has some liability stemming from opioid-related pharmaceutical produ...
More








